Search Result

Results for "

β-glucuronidase inhibitor

" in MedChemExpress (MCE) Product Catalog:

By Targets:	β-glucuronidase (17) Antibody-Drug Conjugates (ADCs) (1) Apoptosis (2) Bacterial (6) Carbonic Anhydrase (3) Carboxylesterase (CES) (1) DNA/RNA Synthesis (1) Drug Intermediate (1) Endogenous Metabolite (1) Photosensitizer (1) Topoisomerase (2)
By Research Areas:	Cancer (11) Infection (4) Inflammation/Immunology (3) Metabolic Disease (7) Neurological Disease (3)

Inhibitors & Agonists

Fluorescent Dye

Natural
Products

Targets Recommended: β-glucuronidase

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-D1460

Fluorescein Di-β-D-Glucuronide	β-glucuronidase Bacterial	Infection
Fluorescein Di-β-D-Glucuronide, a fluorescent probe, can be utilized to non-invasively image the intestinal bacterial β-glucuronidase activity in nude mice. Fluorescein Di-β-D-Glucuronide-based imaging reveals the in vitro and in vivo activity of intestinal bacterial β-glucuronidase, which would facilitate pharmacodynamic studies of specific bacterial β-glucuronidase inhibitors in animal studies .

HY-103081

β-Glucuronidase-IN-1	β-glucuronidase Bacterial	Infection Cancer
β-Glucuronidase-IN-1 is a potent, selective, uncompetitive, and orally active E. coli bacterial β-glucuronidase inhibitor, exhibiting an IC₅₀ and a K_i of 283 nM and 164 nM, respectively .

HY-134453A

D-Saccharic acid 1,4-lactone hydrate 1 Publications Verification	β-glucuronidase Apoptosis	Cancer
D-Saccharic acid 1,4-lactone hydrate is an orally active *β-glucuronidase* inhibitor (IC₅₀=48.4 μM). D-Saccharic acid 1,4-lactone hydrate can be used as a standard agent compared with novel β-glucuronidase inhibitors. D-Saccharic acid 1,4-lactone hydrate possesses anticarcinogenic, detoxifying, and antioxidant properties .

HY-119621

Aceglatone	β-glucuronidase DNA/RNA Synthesis Apoptosis	Cancer
Aceglatone, an antineoplastic agent, is a *β-glucuronidase* inhibitor. Aceglatone is a compound that inhibits colon carcinogenesis and prevents the induction of colon cancer by inhibiting the hydrolysis of glucuronides. Aceglatone reduces cell proliferation, induces apoptosis and inhibits DNA synthesis in human colon cancer cells .

HY-161341

β-Glucuronidase responsive conjugate 1	Photosensitizer	Cancer
β-Glucuronidase responsive conjugate 1 (compound 3) is a well-balanced photosensitizer which has photodynamic activity. β-Glucuronidase responsive conjugate 1 inhibits T-24 cell viability and growth with an IC₅₀ of 0.2 μM. β-Glucuronidase responsive conjugate 1 can used to study bladder cancers .

HY-150977

β-Glucuronidase/hCAII-IN-2	Carbonic Anhydrase	Neurological Disease Metabolic Disease Cancer
β-Glucuronidase/hCAII-IN-2 (Compound 12e) is a potent *β-glucuronidase* and hCA II inhibitor with an IC₅₀ of 670.7 μM and 21.77 μM, respectively .

HY-150976

β-Glucuronidase/hCAII-IN-1	Carbonic Anhydrase β-glucuronidase	Neurological Disease Metabolic Disease Cancer
β-Glucuronidase/hCAII-IN-2 (Compound 12e) is a potent *β-glucuronidase* and hCA II inhibitor with an IC₅₀ of 440.1 μM and 4.91 μM, respectively .

HY-162884

β-Glucuronidase-IN-4	β-glucuronidase	Infection
EcGUS-IN-1 (Compound E-9) is a non-competitive *β-glucuronidase* inhibitor, with an IC₅₀ of 2.68 μM and a K_i value of 1.64 μM. EcGUS-IN-1 can improve gastrointestinal adverse events (GIAE) caused by Escherichia coli infection by inhibiting E. coli *β-glucuronidase* activity .

HY-173397

β-Glucuronidase-IN-3	β-glucuronidase Bacterial	Metabolic Disease
β-Glucuronidase-IN-3 (Compound 49) is a covalent allosteric *β-glucuronidase* inhibitor. β-Glucuronidase-IN-3 has potent inhibitory activity against Escherichia coli β-glucuronidase (EcGUS) (IC₅₀: 12.9 nM). β-Glucuronidase-IN-3 exerts its inhibitory effect by reversibly covalently modifying the cysteine residues (Cys28, Cys443, and Cys197) of EcGUS. β-Glucuronidase-IN-3 can be used in the study of intestinal microbiota-related diseases, especially to alleviate the toxic side effects of Irinotecan (HY-16562) and nonsteroidal anti-inflammatory drugs (NSAIDs) .

HY-N1322

Sanggenol A	Bacterial β-glucuronidase	Others
Sanggenol A acts as a dual inhibitor of nitrofuranone reduction mediated by the intestinal microbial nitrification reductases EcNfsA and EcNfsB. In addition, Sanggenol A is also an effective inhibitor of intestinal bacterial β-glucuronidase .

HY-N2998

Ganoderenic acid A	β-glucuronidase	Metabolic Disease
Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of *β-glucuronidase*. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury .

HY-N7529

Siastatin B	Endogenous Metabolite β-glucuronidase	Others
Siastatin B is an effective broad-spectrum glycosidase inhibitor that can effectively inhibit the activities of sialidase, *β-D-glucuronidase, N-acetyl-glucosaminidase, β-glucuronidase, and human heparinase* .

HY-150973

hCAII-IN-4	Carbonic Anhydrase β-glucuronidase	Neurological Disease Metabolic Disease Cancer
hCAII-IN-4 (Compound 12j) is a potent hCA II inhibitor with an IC₅₀ of 7.78 μM. hCAII-IN-4 also inhibits *β-glucuronidase* with an IC₅₀ of 773.9 μM .

HY-N1733

2′-Hydroxydaidzein 1 Publications Verification	β-glucuronidase	Inflammation/Immunology
2′-Hydroxydaidzein is a metabolite. 2′-Hydroxydaidzein inhibits the release of chemical mediator from inflammatory cells. 2′-Hydroxydaidzein significantly inhibits lysozyme and β-glucuronidase release from rat neutrophils, which is stimulated with fMLP/CB, respectively .

HY-N3413

Kushenol X	Carboxylesterase (CES) β-glucuronidase	Metabolic Disease
Kushenol X, a flavonoid compound isolated from the roots of Sophora flavescens. Kushenol X is a potent *β-glucuronidase* and human carboxylesterase 2 (hCE2) inhibitor with IC₅₀s of 2.07 μM and 3.05 μM, respectively .

HY-N9975

4'',5''-Dehydroisopsoralidin	β-glucuronidase	Inflammation/Immunology Cancer
4'',5''-Dehydroisopsoralidin is a *β-glucuronidase* inhibitor (IC₅₀: 6.3 μM). 4'',5''-Dehydroisopsoralidin has anti-inflammatory and anti-oxidative effects. 4'',5''-Dehydroisopsoralidin can be used in the research of inflammation and cancners .

HY-W345885

Saccharic acid	β-glucuronidase	Metabolic Disease
Saccharic acid is a competitive inhibitor of *β-glucuronidase*. Saccharic acid considerably retards hydrolysis of the glucuronide of 'l-ortho-hydroxyphenylazo-2-naph-thol' by frozen mouse kidney sections, but has no effect on liver regeneration following damage and on growth in infant mice .

HY-151168

3-Chlorogentisyl alcohol	β-glucuronidase Bacterial	Inflammation/Immunology Cancer
3-Chlorogentisyl alcohol is a potent E. coli *β-glucuronidase* inhibitor with an IC₅₀ value of 0.74 μM, an K_i value of 0.58 μM. 3-Chlorogentisyl alcohol shows antiproliferative activity. 3-Chlorogentisyl alcohol has the potential for the research of anti-cancer and anti-inflammatory therapies .

HY-148044

UNC10201652	β-glucuronidase Bacterial	Infection
UNC10201652 is a potent Loop 1 (L1)-specific gut bacterial β-glucuronidase (GUSs) inhibitor with an IC₅₀ value of 0.117 μM for E. coli GUS. UNC10201652 can block SN-38 glucuronide (HY-126373) processing only in individuals whose fecal gut microbiota is highly abundant in L1 GUS enzymes .

HY-173639

AZD0516	Antibody-Drug Conjugates (ADCs) Topoisomerase	Cancer
AZD0516 is a first-in-class antibody-drug conjugate (ADC) targeting six-transmembrane epithelial antigen of the prostate-2 (STEAP2). The anti-STEAP2 monoclonal antibody (mAb) is conjugated via interchain cysteines to a maleimide-reactive, β-glucuronidase-cleavable linker (HY-173635) bearing the topoisomerase 1 inhibitor, Exatecan (HY-13631). AZD0516 can be used for the study of prostate cancer .

HY-173703

β-Glu-PAB(CH2NH2)-Exatecan	Topoisomerase Drug Intermediate	Cancer
β-Glu-PAB(CH2NH2)-Exatecan (Compound 9a) is a topoisomerase I inhibitor. β-Glu-PAB(CH2NH2)-Exatecan binds to the topoisomerase I-DNA complex to prevent DNA strand reconnection, thereby inducing DNA breakage and cell apoptosis. β-Glu-PAB(CH2NH2)-Exatecan can be specifically cleaved by β-glucuronidase highly expressed in the tumor microenvironment to release Exatecan for cytotoxic effect. β-Glu-PAB(CH2NH2)-Exatecan is also an intermediate of Mal((3S,3aR,6S,6aR) -hexahydrofuro [3, 2-B]furan-3,6-diamine-PEG12)-β -Glu-Pab-Exatecan. β-Glu-PAB(CH2NH2)-Exatecan is promising for research of cancers .

Cat. No.	Product Name	Type

HY-D1460

Fluorescein Di-β-D-Glucuronide	Fluorescent Dyes/Probes
Fluorescein Di-β-D-Glucuronide, a fluorescent probe, can be utilized to non-invasively image the intestinal bacterial β-glucuronidase activity in nude mice. Fluorescein Di-β-D-Glucuronide-based imaging reveals the in vitro and in vivo activity of intestinal bacterial β-glucuronidase, which would facilitate pharmacodynamic studies of specific bacterial β-glucuronidase inhibitors in animal studies .

Fluorescein Di-β-D-Glucuronide

Fluorescent Dyes/Probes

Fluorescein Di-β-D-Glucuronide, a fluorescent probe, can be utilized to non-invasively image the intestinal bacterial β-glucuronidase activity in nude mice. Fluorescein Di-β-D-Glucuronide-based imaging reveals the in vitro and in vivo activity of intestinal bacterial β-glucuronidase, which would facilitate pharmacodynamic studies of specific bacterial β-glucuronidase inhibitors in animal studies .

Ganoderenic acid A	Triterpenes Human Gut Microbiota Metabolites Microorganisms other families Classification of Application Fields Terpenoids Source classification Metabolic Disease Plants Endogenous metabolite Disease Research Fields	β-glucuronidase
Ganoderenic acid A is a lanostane-type triterpene. Ganoderenic acid A is a potent inhibitor of *β-glucuronidase*. Ganoderenic acid A has a potent hepatoprotective effect against CCl4-induced liver injury .

2′-Hydroxydaidzein 1 Publications Verification	Flavonoids Leguminosae Source classification Crotalaria pallida Ait. Plants Isoflavones	β-glucuronidase
2′-Hydroxydaidzein is a metabolite. 2′-Hydroxydaidzein inhibits the release of chemical mediator from inflammatory cells. 2′-Hydroxydaidzein significantly inhibits lysozyme and β-glucuronidase release from rat neutrophils, which is stimulated with fMLP/CB, respectively .

Kushenol X	Flavanonols Flavonoids Classification of Application Fields Leguminosae Source classification Phenols Polyphenols Metabolic Disease Sophora flavescens Aiton Plants Disease Research Fields	Carboxylesterase (CES) β-glucuronidase
Kushenol X, a flavonoid compound isolated from the roots of Sophora flavescens. Kushenol X is a potent *β-glucuronidase* and human carboxylesterase 2 (hCE2) inhibitor with IC₅₀s of 2.07 μM and 3.05 μM, respectively .

Saccharic acid	Human Gut Microbiota Metabolites Microorganisms Source classification Endogenous metabolite	β-glucuronidase
Saccharic acid is a competitive inhibitor of *β-glucuronidase*. Saccharic acid considerably retards hydrolysis of the glucuronide of 'l-ortho-hydroxyphenylazo-2-naph-thol' by frozen mouse kidney sections, but has no effect on liver regeneration following damage and on growth in infant mice .

Sanggenol A	Flavonoids Flavones Source classification Plants Moraceae Morus alba Linn.	Bacterial β-glucuronidase
Sanggenol A acts as a dual inhibitor of nitrofuranone reduction mediated by the intestinal microbial nitrification reductases EcNfsA and EcNfsB. In addition, Sanggenol A is also an effective inhibitor of intestinal bacterial β-glucuronidase .

4'',5''-Dehydroisopsoralidin	Classification of Application Fields Solanum lyratum Thunberg Coumarins Phenylpropanoids Solanaceae Plants Inflammation/Immunology Disease Research Fields Cancer	β-glucuronidase
4'',5''-Dehydroisopsoralidin is a *β-glucuronidase* inhibitor (IC₅₀: 6.3 μM). 4'',5''-Dehydroisopsoralidin has anti-inflammatory and anti-oxidative effects. 4'',5''-Dehydroisopsoralidin can be used in the research of inflammation and cancners .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks